Dx Profiler: Can Metastatic Cancer with Diagnostic Ambiguity Be Treated Based on Mutational Status Alone?

  • Review of the Initial Results from Basket Trials
  • Implications of Initial Results in Patients with┬áMetastatic Cancer and Diagnostic Ambiguity
  • Improving Diagnostic Certainty: The Role of┬áMolecular Assays in Challenging Cases
  • Performance of the CancerTYPE ID┬áMolecular Classifier

Can Metastatic Cancer with Diagnostic Ambiguity Be Treated Based on Mutational Status Alone?

The application of molecularly targeted cancer therapies has rapidly expanded in the past 2 decades. The identification of genetic mutations in tumors has led to a growing list of therapies developed to specifically target those alterations. Indeed, molecularly targeted therapies—along with predictive biomarker testing and site-specific chemotherapy—have significantly improved the [ Read More ]

Wayne Kuznar